Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid
- 1 June 1988
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 26 (2) , 103-106
- https://doi.org/10.1016/0306-9877(88)90061-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Genetic and molecular aspects of demyelinationImmunology Today, 1986
- Treatment of experimental allergic encephalomyelitis with myelin basic protein: Which route is best?Neurochemical Research, 1984
- Double-blind Trial of Linoleic Acid in Multiple SclerosisArchives of Neurology, 1983
- Influence of cortisone on immunologic tolerance in vivo: Cortisone prolongs the duration of unresponsiveness but fails to affect its inductionCellular Immunology, 1982
- The pathogenesis and therapy of multiple sclerosis is based upon the requirement of a combination of myelin antigens for autoimmune demyelinationJournal of Neuroimmunology, 1982
- Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeysAnnals of Neurology, 1979
- Has myelin basic protein received a fair trial in the treatment of multiple sclerosis?Annals of Neurology, 1979
- Failure of basic protein therapy for multiple sclerosisZeitschrift für Neurologie, 1977
- Myelin Basic Protein Administration in Multiple SclerosisArchives of Neurology, 1973
- Allergic Encephalomyelitis: Passive Transfer Prevented by EncephalitogenScience, 1968